Amadix (private company)

See something wrong or missing? Let us know
Offices:Valladolid, Madrid
Business model:B2B

Amadix is a biotechnology company constituted by the partners of TCD Pharma for the development of diagnostic tools in the area of ​​oncology, with several very advanced programs in lung and colon cancer. Its solution, called Colofast, allows to detect if a healthy person will suffer from colon cancer up to fifteen years before showing the first symptoms.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 6.38M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Amadix

Name Criteria
Spain Ability Pharma
63%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Total raised in a similar range: 5M - 10M USD
Spain Oxolife SL
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Total raised in a similar range: 5M - 10M USD
Germany Aignostics
48%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Norway Curida
48%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Sweden Gradientech
48%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Sweden iCellate
48%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Myricx Pharma
48%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Spain Oncomatryx
48%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Spain Parlem Telecom
48%
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • At least one other investor: TheCrowdAngel
  • Total raised in a similar range: 5M - 10M USD
Germany Perfood
48%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Top